Reduced CT + Anti-PD-1 as First Line Tx in Vulnerable Older Adults w/Adv <50% PD-L1 Non-Small Cell Lung Cancer (NSCLC)
for
Non-Small Cell Lung Cancer, NSCLC,
Location: Tappahannock VA, Richmond VA
Sponsor: Virginia Commonwealth University
Sex: All
Age: 18+
Code: NCT06731413
Phase2, Recruiting
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
for
Breast, Metastatic, Triple Negative, Cancer,
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18 - 70+
Code: NCT04333706
Phase1, Phase2, Recruiting
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
for
Esophageal Cancer, Head and Neck Cancer, Lung Cancer,
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: All
Age: 21 - 70+
Code: NCT00900419
Recruiting
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
for
Large Cell Lymphoma, Diffuse, Relapsed Cancer,
Location: Charlottesville VA, Detroit MI, Indianapolis IN,
Sponsor: Dipenkumar Modi
Sex: All
Age: 18+
Code: NCT05852717
Phase2, Recruiting
Pembrolizumab for Advanced NSCLC and PS 2-3
for
Non-Small Cell Lung Cancer (NSCLC)
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai
Sex: All
Age: 18+
Code: NCT05589818
Phase2, Recruiting
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
for
Small Cell Lung Cancer, Small Cell Lung Carcinoma
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT04199741
Phase1, Phase2, Recruiting
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy
for
Lung Cancer, Nonsmall Cell
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine
Sex: All
Age: 18+
Code: NCT04691817
Phase1, Phase2, Recruiting
Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix
for
Cervical Large Cell Neuroendocrine Carcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 0+
Code: NCT04723095
Recruiting
Access to Genetic Testing in Underserved Patients With Cancer
for
Breast Carcinoma, Male Breast Carcinoma,
Location: Rochester NY, Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT06422455
Recruiting
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing